Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2008-12-17

Clinical Trial Update: Non Alcoholic Fatty Liver Disease (NAFLD) in Hong Kong

View source ↗

Summary

A clinical trial update about non-alcoholic fatty liver disease in Hong Kong, sponsored by the Hospital Authority; the trial status is currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Hospital Authority, Hong Kong | Conditions: Fatty Liver | Status: UNKNOWN